Home > Boards > US Listed > Biotechs > Atossa Genetics, Inc. (ATOS)

This is how the market works my friend.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
airahim Member Profile
 
Followed By 2
Posts 173
Boards Moderated 0
Alias Born 10/03/12
160x600 placeholder
Atossa Genetics Announces Second Quarter 2019 Financial Results and Provides Company Update GlobeNewswire Inc. - 8/13/2019 1:26:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 8:33:56 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 8:32:21 AM
Atossa Genetics CEO Steven Quay Gives Tedx Talk At University of Washington Regarding the the Relationship of Dense Breast Ti... GlobeNewswire Inc. - 7/30/2019 8:30:00 AM
Atossa Genetics Provides Information on FDA Expanded Access Policy and Requests GlobeNewswire Inc. - 7/17/2019 8:30:00 AM
Atossa Genetics Announces New Proprietary Modified-Release Oral Endoxifen Tablet; Phase 1 Clinical Trial Initiated GlobeNewswire Inc. - 7/11/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2019 12:49:44 PM
Atossa Genetics’ Preliminary Phase 2 Study Achieves Primary Endpoint: Topical Endoxifen Rapidly Reduces Breast Density GlobeNewswire Inc. - 6/27/2019 8:00:00 AM
Atossa Genetics to Present at the 9th Annual LD Micro Invitational on June 4, 2019 GlobeNewswire Inc. - 5/30/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2019 4:32:45 PM
Atossa Genetics Announces First Quarter 2019 Financial Results and Provides Company Update GlobeNewswire Inc. - 5/13/2019 5:21:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2019 4:35:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2019 4:32:57 PM
Atossa Genetics Provides Clinical Update at the 4th Annual Precision: Breast Cancer World R&D Summit GlobeNewswire Inc. - 4/25/2019 12:00:00 PM
Atossa Genetics to Present at the 4th Annual Precision: Breast Cancer World R&D Summit April 25, 2019 GlobeNewswire Inc. - 4/22/2019 8:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/12/2019 12:02:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/28/2019 4:34:52 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/28/2019 4:34:51 PM
Atossa Genetics Announces Year End 2018 Financial Results and Provides Company Update GlobeNewswire Inc. - 3/28/2019 4:30:00 PM
Atossa Genetics Announces Institutional Review Board Approval of Oral Endoxifen as Post-Mastectomy Treatment for a U.S. Breas... GlobeNewswire Inc. - 3/26/2019 8:30:00 AM
Atossa Genetics Announces Receipt of $10 Million GlobeNewswire Inc. - 3/18/2019 8:30:00 AM
Atossa Genetics Announces FDA Approval of Oral Endoxifen for “Expanded Access” as Post-Mastectomy Treatment for a U.S. Br... GlobeNewswire Inc. - 3/14/2019 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2019 1:32:19 PM
Atossa Genetics Reports Results From “Expanded Access” Program for a U.S. Breast Cancer Patient Taking Oral Endoxifen: Si... GlobeNewswire Inc. - 2/7/2019 8:30:00 AM
Atossa Genetics Provides Breast Cancer Prevention Recommendations to the United States Preventative Services Task Force GlobeNewswire Inc. - 2/4/2019 8:30:00 AM
airahim   Thursday, 03/14/19 07:17:41 PM
Re: tiger3 post# 2005
Post # of 2984 
This is how the market works my friend. Nothing shoots straight up, charts have dips so the weak hands are shook out. This will pop hard in the morning, volume is too strong today

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist